Aviptadil, a vasodilator originally developed to treat erectile dysfunction, led to a 72% survival in...
Up To Date
Latest News
Polyphor has secured $3.3m from the Cystic Fibrosis Foundation as support for clinical Phase I/IIa testing of...
12 interactive workshops, five plenary sessions and more than 3,000 registered attendees – last week the...
More than 3,000 attendees are participating in the Global Bioeconomy Summit, currently taking place virtually...
As investments into COVID-19 therapeutics is no EU priority, development is lagging behind the US. Now, CORAT...
After BioNTech SE reported that its COVID-19 vaccine candidate BNT162b2 was over 90% efficient in a Phase III...
Share
